NCUK Virtual Patient Handbook

s - only 1 has current (2023) NICE approval - these are:

for pheochromocytomas and paragangliomas

e used in SIRT).

used for GEP-NETs

in the UK for treating unresectable or metastatic, progressive, well- stroenteropancreatic neuroendocrine tumours (NETs) in adults.

indications for usage of 177Lu Radioligand Therapy (to include other ades, e.g., NECs and Grade 3 NETs).

d Alpha Particle Therapy.

Click here to watch the full video about the patient experience of radioligand therapy

Made with FlippingBook - Share PDF online